Published in Infect Immun on March 01, 1984
Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev (1998) 4.14
Unique phenotype of opaque cells in the white-opaque transition of Candida albicans. J Bacteriol (1987) 3.67
Calcineurin is essential for Candida albicans survival in serum and virulence. Eukaryot Cell (2003) 1.98
Variability in expression of cell surface antigens of Candida albicans during morphogenesis. Infect Immun (1986) 1.82
Identification of wall-specific antigens synthesized during germ tube formation by Candida albicans. Infect Immun (1989) 1.78
Ultrastructural and biochemical studies of two dynamically expressed cell surface determinants on Candida albicans. Infect Immun (1986) 1.70
Adherence of Candida albicans germ tubes to plastic: ultrastructural and molecular studies of fibrillar adhesins. Infect Immun (1988) 1.60
Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect Immun (1986) 1.58
Variable expression of a surface determinant during proliferation of Candida albicans. Infect Immun (1988) 1.54
Enzymatic release of germ tube-specific antigens from cell walls of Candida albicans. Infect Immun (1985) 1.54
Identification of two germ-tube-specific cell wall antigens of Candida albicans. Infect Immun (1986) 1.43
A monoclonal antibody to a cell wall component of Candida albicans. Infect Immun (1986) 1.30
Antigenic differences in the surface mannoproteins of Candida albicans as revealed by monoclonal antibodies. Infect Immun (1988) 1.29
Antigenic differences between mannoproteins of germ tubes and blastospores of Candida albicans. Infect Immun (1987) 1.20
Molecular cloning of cDNA and analysis of protein secondary structure of Candida albicans enolase, an abundant, immunodominant glycolytic enzyme. J Bacteriol (1992) 1.14
Characterization of Candida albicans cell wall antigens with monoclonal antibodies. Infect Immun (1993) 1.12
A monoclonal antibody that defines a surface antigen on Candida albicans hyphae cross-reacts with yeast cell protoplasts. Infect Immun (1990) 1.11
Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans. J Clin Pathol (1985) 1.10
Caveats in the investigation of form-specific molecules of Candida albicans. Infect Immun (1990) 1.07
Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae. J Clin Microbiol (2003) 1.01
Recognition of binding sites on Candida albicans by monoclonal antibodies to human leukocyte antigens. Infect Immun (1990) 0.99
Genetic organization and mRNA expression of enolase genes of Candida albicans. J Bacteriol (1995) 0.97
Role of actin cytoskeletal dynamics in activation of the cyclic AMP pathway and HWP1 gene expression in Candida albicans. Eukaryot Cell (2007) 0.92
Cutaneous defenses against dermatophytes and yeasts. Clin Microbiol Rev (1995) 0.91
Expression of surface hydrophobic proteins by Candida albicans in vivo. Infect Immun (1995) 0.91
Tubulin and high-molecular-weight polypeptides as Giardia lamblia antigens. Infect Immun (1984) 0.90
Involvement of a cell wall receptor in the mode of action of an anti-Candida toxin of Pichia anomala. Antimicrob Agents Chemother (1990) 0.83
Cross-reactivity between Candida albicans and human ovarian carcinoma as revealed by monoclonal antibodies PA10F and C6. Br J Cancer (1998) 0.82
Molecular probe for typing strains of Candida albicans. J Clin Microbiol (1996) 0.81
Dodonaea viscosa var. angustifolia Inhibits Germ Tube and Biofilm Formation by C. albicans. Evid Based Complement Alternat Med (2013) 0.75
A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods (1981) 10.77
DITHIOTHREITOL, A NEW PROTECTIVE REAGENT FOR SH GROUPS. Biochemistry (1964) 10.04
Adherence of Candida albicans to human buccal epithelial cells. Infect Immun (1978) 3.05
Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J Clin Invest (1978) 2.72
Radiolabeling of proteins by reductive alkylation with [14C]formaldehyde and sodium cyanoborohydride. Anal Biochem (1978) 2.41
Fungal morphogenesis: cell wall construction in Mucor rouxii. Science (1969) 2.17
Relationship between germination of Candida albicans and increased adherence to human buccal epithelial cells. Infect Immun (1980) 2.13
Germ tube induction in Candida albicans. Can J Microbiol (1980) 2.04
Commitment to germ tube or bud formation during release from stationary phase in Candida albicans. Exp Cell Res (1979) 2.02
POLYSACCHARIDE ANTIGENS OF CANDIDA CELL WALL. J Immunol (1964) 2.01
Synthesis of nueic acids and proteins in the dimorphic forms of Candida albicans. Sabouraudia (1970) 1.68
Immunofluorescence study of Candida albicans in candidiasis, carriers and controls. J Pathol Bacteriol (1966) 1.66
Immunogenicity of Mycoplasma pneumoniae. Infect Immun (1971) 1.60
Cytoplasmic antigens unique to the mycelial or yeast phase of Candida albicans. Infect Immun (1975) 1.57
Relevance of antigenicity of Candida albicans growth phases to diagnosis of systemic candidiasis. Br Med J (1973) 1.47
Strain variation and morphogenesis of yeast- and mycelial-phase Candida albicans in low-sulfate, synthetic medium. J Bacteriol (1980) 1.41
Analysis of cytoplasmic antigens of the yeast and mycelial phases of Candida albicans by two-dimensional electrophoresis. Infect Immun (1980) 1.28
Variation in the lethal response in mice to yeast-like and pseudohyphal forms of Candida albicans. Can J Microbiol (1975) 1.18
Antibodies to germinating and yeast cells of Candida albicans in human and rabbit sera. J Clin Pathol (1979) 1.15
Differential expression of cytoplasmic proteins during yeast bud and germ tube formation in Candida albicans. Can J Microbiol (1981) 1.14
The temporal regulation of protein synthesis during synchronous bud or mycelium formation in the dimorphic yeast Candida albicans. Dev Biol (1982) 1.11
Cytochemical and ultrastructural studies of Candida albicans. II. Evidence for a cell wall coat using concanavalin A. J Ultrastruct Res (1981) 1.09
Ultrastructure of human cutaneous candidosis. J Invest Dermatol (1982) 1.09
Attachment of gonococcal pili to lectin-resistant clones of Chinese hamster ovary cells. Infect Immun (1982) 1.09
The ultrastructure of Candida albicans infections. Can J Microbiol (1981) 1.08
Relationship between phosphate content and serological activities of the mannans of Candida albicans strains NIH A-207, NIH B-792, and J-1012. J Bacteriol (1979) 1.04
Indirect immunofluorescence assay for antibody to germ tube of Candida albicans--a new diagnostic test. J Clin Pathol (1976) 1.02
Differential protein synthesis in Candida albicans during blastospore formation at 24.5 degrees C and during germ tube formation at 37 degrees C. J Gen Microbiol (1983) 0.99
A serological investigation of hyphal growth in Fusarium culmorum. Arch Mikrobiol (1968) 0.97
Periodate oxidation of methionine in proteins. Anal Biochem (1982) 0.94
Morphological commitment in Candida albicans. Can J Microbiol (1981) 0.91
Different immunofluorescent titres of Candida albicans blastospores and pseudohyphae. Mycopathol Mycol Appl (1974) 0.87
Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob Agents Chemother (1985) 3.66
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J Immunol (1975) 3.41
Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis (1979) 3.12
Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum. Antimicrob Agents Chemother (1986) 3.08
Correlation of circulating capsular polysaccharide with bacteremia in pneumococcal pneumonia. Infect Immun (1972) 2.93
Heat-lability and organic solvent-solubility of mycoplasma antigens. Ann N Y Acad Sci (1967) 2.92
Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis (2000) 2.63
Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA (1970) 2.58
Epidemiology of Mycoplasma pneumoniae infection in families. JAMA (1966) 2.49
Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol (1972) 2.37
Enhancement of rhinovirus plaque formation in human heteroploid cell cultures by magnesium and calcium. J Bacteriol (1966) 2.15
Serological comparison of ten glycolytic Mycoplasma species. J Bacteriol (1969) 2.13
Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: report of four cases. J Infect Dis (1973) 2.11
Tetracycline resistance and tetM in pathogenic urogenital bacteria. Antimicrob Agents Chemother (1986) 2.01
Characterization of the group antigen of Chlamydia trachomatis. Infect Immun (1971) 1.86
Prevalence of Mycoplasma genitalium determined by DNA probe in men with urethritis. Lancet (1988) 1.86
Conjugal transfer of transposon Tn916 from Streptococcus faecalis to Mycoplasma hominis. J Bacteriol (1987) 1.84
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. II. A trachoma-LGV-specific antigen. J Immunol (1975) 1.73
Antigenic groupings of 90 rhinovirus serotypes. Infect Immun (1982) 1.73
Morphology and ultrastructure of Mycoplasma pneumoniae spherules. J Bacteriol (1971) 1.68
Role of arginine deiminase in growth of Mycoplasma hominis. J Bacteriol (1976) 1.64
Principles, problems, and strategies in the use of antigenic mixtures for the enzyme-linked immunosorbent assay. J Clin Microbiol (1983) 1.64
Effect of urea concentration on growth of Ureaplasma urealyticum (T-strain mycoplasma). J Bacteriol (1977) 1.64
Antigenic analysis of Legionella pneumophila and Tatlockia micdadei (Legionella micdadei) by two-dimensional (crossed) immunoelectrophoresis. Infect Immun (1982) 1.60
Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group. Am Rev Respir Dis (1975) 1.60
Enzymatic release of germ tube-specific antigens from cell walls of Candida albicans. Infect Immun (1985) 1.54
Mycoplasma genitalium and non-gonococcal urethritis. Lancet (1994) 1.52
Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group. N Engl J Med (1966) 1.52
Isolation of cytomegalovirus from a cohort of 100 infants throughout the first year of life. Proc Soc Exp Biol Med (1969) 1.50
Serological comparison of five arginine-utilizing Mycoplasma species by two-dimensional immunoelectrophoresis. Infect Immun (1974) 1.50
Characterization of membrane and cytoplasmic antigens of Mycoplasma arginini by two-dimensional (crossed) immunoelectrophoresis. Infect Immun (1977) 1.48
Distinction of species and strains of mycoplasmas (mollicutes) by genomic DNA fingerprints with an rRNA gene probe. J Clin Microbiol (1988) 1.48
The principal protein antigens of isolates of Mycoplasma pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period. Infect Immun (1987) 1.48
Haemophilus influenzae type b isolates show antigenic variation in a major outer membrane protein. Infect Immun (1984) 1.44
Characterization of Mycoplasma pulmonis variants isolated from rabbits. I. Identification and properties of isolates. J Bacteriol (1967) 1.43
Mycoplasma salivarium in human gingival sulci. J Periodontal Res (1970) 1.40
Characterizion of Mycoplasma pulmonis variants isolated from rabbits. II. Basis for differentiation of antigenic subtypes. J Bacteriol (1967) 1.39
Immunoblotting for determination of the antigenic specificities of antibodies to the Mycoplasmatales. Isr J Med Sci (1984) 1.31
Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA (1979) 1.31
Analysis of serum pooling schemes for identification of large numbers of viruses. Am J Epidemiol (1970) 1.30
Immunochemical analysis of serologically active lipids of Mycoplasma pneumoniae. J Bacteriol (1968) 1.30
Complement dependent killing of Mycoplasma pneumoniae by antibody: kinetics of the reaction. J Immunol (1970) 1.30
Antigenic differences in the surface mannoproteins of Candida albicans as revealed by monoclonal antibodies. Infect Immun (1988) 1.29
Immunogenicity of rhinoviruses. Proc Soc Exp Biol Med (1970) 1.29
Isolation of TRIC agents and mycoplasma from the genito-urinary tracts of patients of a venereal disease clinic. Am J Ophthalmol (1967) 1.28
Isolation of Mycoplasma hominis, T-strains, and cytomegalovirus from the cervix of pregnant women. Am J Obstet Gynecol (1970) 1.26
Evaluation of the detection limits of PCR for identification of Mycoplasma pneumoniae in clinical samples. Mol Cell Probes (1994) 1.25
Antigenic differences between mannoproteins of germ tubes and blastospores of Candida albicans. Infect Immun (1987) 1.20
Mycoplasma pneumoniae in the community. Am J Epidemiol (1971) 1.17
Early postpartum endometritis: the role of bacteria, genital mycoplasmas, and Chlamydia trachomatis. Obstet Gynecol (1989) 1.17
Demonstration of dual rhinovirus infection in humans by isolation of different serotypes in human heteroploid (HeLa) and human diploid fibroblast cell cultures. J Clin Microbiol (1977) 1.15
Epidemiology of viral and mycoplasmal agents associated with childhood lower respiratory illness in a civilian population. J Pediatr (1971) 1.13
Polymicrobial early postpartum endometritis with facultative and anaerobic bacteria, genital mycoplasmas, and Chlamydia trachomatis: treatment with piperacillin or cefoxitin. J Infect Dis (1986) 1.13
Chromosomal DNA probes for the identification of Bacteroides species. J Gen Microbiol (1987) 1.12
Effect of magnesium on replication of rhinovirus HGP. J Virol (1967) 1.11
Differences in incorporation of nucleic acid bases and nucleosides by various Mycoplasma and Acholeplasma species. J Bacteriol (1978) 1.11
Differences in arginine requirement for growth among arginine-utilizing Mycoplasma species. J Bacteriol (1974) 1.11
TetM tetracycline-resistant determinants in Ureaplasma urealyticum. Pediatr Infect Dis (1987) 1.08
Characterization of trachoma antigens protective against mouse toxicity. Am J Ophthalmol (1967) 1.08
Inhibition of the growth of Ureaplasma urealyticum by a new urease inhibitor, flurofamide. Yale J Biol Med (1984) 1.07
Acquisition of mycoplasmata and T-strains during infancy. J Infect Dis (1970) 1.06
Cytomegalic inclusion disease of infancy. Pediatrics (1966) 1.05
Cross relationships among 37 rhinoviruses demonstrated by virus neutralization with potent monotypic rabbit antisera. Infect Immun (1973) 1.05
Antigenic analysis of three strains of Mycoplasma arginini by two-dimensional immunoelectrophoresis. J Immunol (1975) 1.04
Cranial neuropathy, myeloradiculopathy, and myositis: complications of Mycoplasma pneumoniae infection. Arch Neurol (1979) 1.04
Broad antigenic relationships among rhinovirus serotypes revealed by cross-immunization of rabbits with different serotypes. J Immunol (1975) 1.04
Serological cross-reaction between lipids of Mycoplasma pneumoniae and Mycoplasma neurolyticum. Infect Immun (1971) 1.03
Epidemiological studies of Mycoplasma pneumoniae infections in civilians. Ann N Y Acad Sci (1967) 1.02
Second attacks of pneumonia due to Mycoplasma pneumoniae. J Infect Dis (1977) 1.02
Immunochemical characterization of a heat-stable surface antigen of Mycoplasma pulmonis expressing both species-specific and strain-specific determinants. Infect Immun (1984) 1.02
Plaque assay and improved yield of human coronaviruses in a human rhabdomyosarcoma cell line. J Clin Microbiol (1979) 1.01
Mycoplasma pneumoniae infection followed by Haemophilus influenzae pneumonia and bacteremia. Am Rev Respir Dis (1975) 1.01
In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test. Antimicrob Agents Chemother (1999) 1.00
Sanitization of dentures by several denture hygiene methods. J Prosthet Dent (1984) 0.96
Prevention of autolysis in suspensions of Neisseria gonorrhoeae by mercuric ions. J Bacteriol (1978) 0.95
Virulence of ureaplasmal urease for mice. Infect Immun (1991) 0.94
Isolation of mycoplasmas and bacteria from the blood of postpartum women. Am J Obstet Gynecol (1982) 0.94
Reciprocal neutralizing cross-reaction between rhinovirus types 9 and 32. J Immunol (1970) 0.93
Characteristics of Ureaplasma urealyticum urease. J Bacteriol (1988) 0.93
Metabolic effects of volatile anesthetics in cell culture. Anesthesiology (1968) 0.93
Application of charge shift electrophoresis to antigenic analysis of mycoplasmic membranes by two-dimensional (crossed) immunoelectrophoresis. Infect Immun (1978) 0.92
Rapid method for simultaneous detection of the arginine dihydrolase system and amino acid decarboxylases in microorganisms. J Clin Microbiol (1982) 0.92
Naturally acquired immunity to pneumonia due to Mycoplasma pneumoniae. J Infect Dis (1983) 0.90
Three-dimensional morphology, ultrastructure, and replication of Mycoplasma felis. J Bacteriol (1970) 0.90
Comparative poliovirus permeability of silver, polycarbonate, and cellulose membrane filters. Appl Microbiol (1970) 0.89
Human antibody response to outer membrane proteins and fimbriae of Haemophilus influenzae type b. Can J Microbiol (1988) 0.89
Serologic heterogeneity of the mycoplasmatales. J Infect Dis (1973) 0.89
Ureaplasma urealyticum upper urinary tract infection: persistence and pathogenicity in a canine model. J Urol (1989) 0.89
Polypeptides and functions of antigens from human coronaviruses 229E and OC43. Infect Immun (1982) 0.89
Repeated Mycoplasma pneumoniae pneumonia after 4 and one-half years. JAMA (1971) 0.89
Characterization of the strain-specific and common surface antigens of Mycoplasma arginini. Infect Immun (1980) 0.88
Humoral immune response to polypeptides of Ureaplasma urealyticum in women with postpartum fever. J Clin Microbiol (1987) 0.87
Growth of Japanese encephalitis virus in cell structure. J Infect Dis (1965) 0.86
Intestinal absorption of intact proteins in normal and protein-deficient rats. Am J Clin Nutr (1974) 0.85
Broadly reactive immunofluorescence test for measurement of immunoglobulin M and G antibodies to Ureaplasma urealyticum in infant and adult sera. J Clin Microbiol (1983) 0.84
Immunogenicity and antigenicity of human coronaviruses 229E and OC43. Infect Immun (1981) 0.84
Antigenic distinctiveness of Mobiluncus curtisii and Mobiluncus mulieris. J Clin Microbiol (1985) 0.83
Antigenic heterogeneity in the 115,000 Mr major surface antigen of Trichomonas vaginalis. J Protozool (1988) 0.83